Stereotaxis (STXS) Capital Expenditures (2010 - 2026)
Stereotaxis' (STXS) quarterly Capital Expenditures came in at $79000.0 in Q1 2026, up 243.48% year-over-year from $23000.0 in Q1 2025, and up 12.86% quarter-over-quarter from $70000.0 in Q4 2025.
Analysis
Stereotaxis (STXS) Capital Expenditures (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has reported Capital Expenditures for 14 consecutive years, with $79000.0 the latest figure, recorded in Q1 2026.
- On a quarterly basis, Capital Expenditures rose 243.48% year-over-year to $79000.0 in Q1 2026; TTM through Mar 2026 was $149000.0, a 325.71% increase from a year earlier, with the FY2025 full-year figure at $93000.0, up 173.53% from the prior year.
- Capital Expenditures was $79000.0 for Q1 2026 at Stereotaxis, up from $70000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $1.2 million in Q1 2022 and troughed at $2000.0 in Q4 2024.
- A 5-year average of $244000.0 and a median of $74500.0 in 2025 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures slumped 98.92% in 2023 and jumped 3400.0% in 2025, its largest moves.
- Over 5 years, Capital Expenditures stood at $369000.0 in 2022, then slumped by 97.29% to $10000.0 in 2023, then tumbled by 80.0% to $2000.0 in 2024, then jumped by 3400.0% to $70000.0 in 2025, then climbed by 12.86% to $79000.0 in 2026.
- The last three Capital Expenditures figures came in at $79000.0 (Q1 2026), $70000.0 (Q4 2025), and $23000.0 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 112.60 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 503.00 Mn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 202.00 Mn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 195.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 66.90 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -96.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 84.70 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 87.50 Mn |
| 10 | Stereotaxis | 129.55 Mn | 114.93 Mn | 3.79 Mn | 79,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 79,000.00 |
| Dec 31, 2025 | 70,000.00 |
| Mar 31, 2025 | 23,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Sep 30, 2023 | 10,000.00 |
| Jun 30, 2023 | 7,000.00 |
| Mar 31, 2023 | 349,000.00 |
| Dec 31, 2022 | 369,000.00 |
| Sep 30, 2022 | 205,000.00 |
| Jun 30, 2022 | 650,000.00 |
| Mar 31, 2022 | 1.15 Mn |
| Dec 31, 2021 | 1.20 Mn |
| Sep 30, 2021 | 51,000.00 |
| Jun 30, 2021 | 116,000.00 |
| Mar 31, 2021 | 34,000.00 |
| Dec 31, 2019 | 13,654.00 |
| Sep 30, 2019 | 5,999.00 |
| Mar 31, 2019 | 9,833.00 |
| Dec 31, 2018 | 9,928.00 |